Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to establish a selection criteria of hepatectomy for patients with multiple hepatocellular carcinomas based on the NDR Scoring System
Multiple hepatocellular carcinomas (HCCs) accounts for 60% to 70% of patients with hepatocellular carcinoma.However,the selection criteria of hepatectomy for patients with multiple HCCs remains controversial.Researches have suggested that part of the patients with multiple HCCs can also benefit from hepatectomy.But,expanding the selection criteria for hepatectomy will increase tumor recurrence rates and reduce the therapeutic effect, more stringent selection criteria will also make part of the patients who should take hepatectomy lose the operation chance. This is a difficult problem in the research of this field.The Barcelona Clinic Liver Cancer (BCLC) system recommends that stage A (number ≤ 3, largest diameter ≤ 3 cm) were suitable for liver resection.However, increasing reports on good outcome after hepatectomy for patients with multiple HCCs have been published.Studies on clonal origin suggest that hepatectomy is a better treatment for multiple HCCs from multicentric origin (MO) than that from intrahepatic metastasis (IM) and the 5-year overall survival rates is 24% to 58%.The investigators established a scoring system(NDR score; N, tumor number; D, total tumor diameter; R, ratio of largest/smallest diameter) based on preoperative data which can accurately predict postoperative long-term survival of patients with multiple HCCs.The formula is as follows: 1×N(N: >3=1; ≤3= 0)+ 2×D(D: >8cm = 1; ≤8cm= 0)+ 1×R(R: >6 = 1; ≤6= 0).The investigators first propose a selection criteria of hepatectomy for patients with multiple HCCs based on this scoring system. Patients with a NDR score 0-2 are recommended for hepatectomy and can benefit from the surgery,and because of the unsatisfied outcome,patients with a NDR score more than 2 are not recommended for hepatectomy.The stringent selection criteria should be expanded so that more patients can benefit from hepatectomy,and the less stringent criteria should be limited to ensure curative effect.So,the investigators' NDR scoring system was more accurate in selecting patients with multiple HCCs for hepatectomy and this article was published on Ann Surg Oncol(2015,22:826).In order to further confirm the rationality of this selection criteria,the investigators would like to propose a prospective randomized controlled study.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Hepatectomy with NDR 0-2 | Experimental | Surgical removal of all lesions for patients with a NDR score 0-2 according to the NDR scoring system |
|
| TACE with NDR 0-2 | Active Comparator | Transarterial chemoembolization for patients with a NDR score 0-2 according to the NDR scoring system |
|
| Hepatectomy with NDR >2 | Experimental | Surgical removal of all lesions for patients with a NDR score more than 2 according to the NDR scoring system |
|
| TACE with NDR >2 | Active Comparator | Transarterial chemoembolization for patients with a NDR score more than 2 according to the NDR scoring system |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hepatectomy | Procedure | Surgical removal of all lesions |
|
| Measure | Description | Time Frame |
|---|---|---|
| overall survival | 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Time to recurrence | 5 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Shen Feng, MD | Contact | 0086-021-25070805 | shenfengdfgd@yahoo.com.cn |
| Name | Affiliation | Role |
|---|---|---|
| Shen Feng, MD | Eastern Hepatobiliary Surgery Hospital, Second Military Medical University | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Eastern hepatobilliary surgery hospital | Recruiting | Shanghai | Shanghai Municipality | 200438 | China |
Not provided
| ID | Term |
|---|---|
| D006528 | Carcinoma, Hepatocellular |
| ID | Term |
|---|---|
| D000230 | Adenocarcinoma |
| D002277 | Carcinoma |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
Not provided
Not provided
| ID | Term |
|---|---|
| D006498 | Hepatectomy |
| ID | Term |
|---|---|
| D013505 | Digestive System Surgical Procedures |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| TACE | Procedure | Transarterial chemoembolization with lipiodol and pirarubicin |
|
| Eastern hepatobilliary surgery hospital | Recruiting | Shanghai | Shanghai Municipality | 200438 | China |
|
| D009369 | Neoplasms |
| D008113 | Liver Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D004066 | Digestive System Diseases |
| D008107 | Liver Diseases |